Left Atrial Appendage (LAA) Occluders

watchman LAA occluder, LAAO registry
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016

November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...

UAB, University of Alabama at Birmingham study, stroke prevention, non-valvular atrial fibrillation, NVAF
News | Atrial Fibrillation | October 25, 2016

October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE ...

SentreHeart, Lariat Suture Delivery Device, financing round, aMAZE Trial
News | Left Atrial Appendage (LAA) Occluders | October 20, 2016

October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of...

SentreHeart, Eclipse Surgical Device, left atrial appendage, LAA closure, first clinical use, Poland
News | Left Atrial Appendage (LAA) Occluders | October 13, 2016

October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical...

CardioKinetix, Parachute device, Heart Failure device therapy

The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently. 

Feature | Heart Failure | September 29, 2016 | Abha Mishra

New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with...

St. Jude Medical, Amplatzer Amulet LAA occluder, left atrial appendage, IDE trial
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016

September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...

Watchman, left atrial appendage closure, LAA occluder

An illustration of a Watchman transcatheter LAA occluder being implanted.

Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...

AtriCure, FROST cryoanalgesia study, William Beaumont Hospital Michigan, cryoICE system
News | Left Atrial Appendage (LAA) Occluders | July 07, 2016

July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont...

AtriCure, AtriClip PRO2 LAA Exclusion System, CE Mark, left atrial appendage occlusion
News | Left Atrial Appendage (LAA) Occluders | July 05, 2016

July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA...

Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell

Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...

St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab | May 19, 2016

May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR...

AtriCure, AtriClip PRO2 LAA Exclusion System, left atrial appendage, FDA clearance
Technology | Left Atrial Appendage (LAA) Occluders | April 29, 2016

April 29, 2016 — AtriCure Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip...

Videos | Left Atrial Appendage (LAA) Occluders | April 15, 2016

David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal...

aMAZE Trial enrollment, The Valley Hospital NJ, atrial fibrillation
News | Left Atrial Appendage (LAA) Occluders | March 16, 2016

March 16, 2016 — The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a...

Overlay Init